Predicting Echocardiographic Stage B2 Myxomatous Mitral Valve Disease in Preclinical Cavalier King Charles Spaniels | VETgirl Veterinary Continuing Education Podcasts

In today's VETgirl online veterinary CE podcast, we’re going to talk about one of my favorite breeds, the super sweet Cavalier King Charles Spaniel (what we’ll Cavaliers from now on, since it’s a mouthful!). Unfortunately, we all know that this breed has horrible myxomatous mitral valve disease. So, if you see Cavaliers in your clinic, when should you decide to put these dogs on heart medications? After all, we know that the initiation of pimobendan can significantly delay the onset of congestive heart failure in dogs with stage B2 myxomatous mitral valve disease (or “mitral valve disease”), and that detection of the transition from stage B1 to B2 in this population of dogs is important so that therapy can be initiated expediently.Sponsored By: Antech